We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Top Buys

Rank Stock Value
1
PLAY icon
Dave & Buster's
PLAY
+$2.84M
2
LYV icon
Live Nation Entertainment
LYV
+$2.81M
3
WWW icon
Wolverine World Wide
WWW
+$2.72M
4
TSLA icon
Tesla
TSLA
+$2.63M
5
CALY
Callaway Golf Company
CALY
+$2.58M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.61M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.99M
3
EXTR icon
Extreme Networks
EXTR
+$2.33M
4
CASY icon
Casey's General Stores
CASY
+$2.21M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMBR
1926
Amber International Holding Ltd
AMBR
$130M
– –
-1,613
Closed -$11K
SMC
1927
Summit Midstream
SMC
$419M
– –
-12,799
Closed -$163K
UCB
1928
United Community Banks
UCB
$4.28B
– –
-23,487
Closed -$709K
EXE
1929
Expand Energy Corp
EXE
$21.5B
– –
-8,055
Closed -$653K
PRSU
1930
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
– –
-9,906
Closed -$274K
JBTM
1931
JBT Marel
JBTM
$6.39B
– –
-6,623
Closed -$731K
NAGE
1932
Niagen Bioscience
NAGE
$247M
– –
-19,176
Closed -$32K
TVRD
1933
Tvardi Therapeutics
TVRD
$23.4M
– –
-3,348
Closed -$1.1M
NVRO
1934
DELISTED
NEVRO CORP.
NVRO
– –
-6,199
Closed -$272K
VOXX
1935
DELISTED
VOXX International Corporation Class A
VOXX
– –
-11,005
Closed -$102K
MTTR
1936
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
– –
-99,717
Closed -$365K
RVNC
1937
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-42,978
Closed -$594K
HTLF
1938
DELISTED
Heartland Financial USA, Inc.
HTLF
– –
-12,138
Closed -$504K
CTLT
1939
DELISTED
CATALENT, INC.
CTLT
– –
-2,119
Closed -$227K
TFFP
1940
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
– –
-3,747
Closed -$529K
HAYN
1941
DELISTED
Haynes International, Inc.
HAYN
– –
-17,712
Closed -$580K
TWKS
1942
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
– –
-47,715
Closed -$673K
INST
1943
DELISTED
Instructure Holdings, Inc.
INST
– –
-17,902
Closed -$406K
PETQ
1944
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
-10,760
Closed -$181K
WKME
1945
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
– –
-22,950
Closed -$232K
HYZN
1946
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
– –
-3,432
Closed -$505K
BIG
1947
DELISTED
Big Lots, Inc.
BIG
– –
-28,087
Closed -$589K
VLD
1948
DELISTED
Velo3D, Inc.
VLD
– –
-1,072
Closed -$52K
MMAT
1949
DELISTED
Meta Materials Inc. Common Stock
MMAT
– –
-3,670
Closed -$378K
TWOU
1950
DELISTED
2U Inc
TWOU
– –
-2,026
Closed -$637K
76 77
78
79 80

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.